Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Sarzi-Puttini P"" wg kryterium: Autor


Tytuł :
Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors.
Autorzy :
Bodio C; Istituto Auxologico Italiano, IRCCS, Experimental Laboratory of Immuno-rheumatology, Milan, Italy.
Grossi C; Istituto Auxologico Italiano, IRCCS, Experimental Laboratory of Immuno-rheumatology, Milan, Italy.
Pregnolato F; Istituto Auxologico Italiano, IRCCS, Experimental Laboratory of Immuno-rheumatology, Milan, Italy.
Favalli EG; Rheumatology Department, ASST Gaetano Pini-CTO, Milan, Italy.
Biggioggero M; Rheumatology Department, ASST Gaetano Pini-CTO, Milan, Italy.
Marchesoni A; Rheumatology Department, ASST Gaetano Pini-CTO, Milan, Italy.
Murgo A; Rheumatology Department, ASST Gaetano Pini-CTO, Milan, Italy.
Filippini M; Rheumatology and Clinical Immunology, ASST Spedali Civili di Brescia, Italy.
Migliorini P; Clinical Immunology, University of Pisa, Italy.
Caporali R; Department of Clinical Sciences and Community Health, University of Milan, Italy; IRCCS Policlinico S. Matteo Foundation, Pavia, Italy.
Pellerito R; Rehumatology, Ospedale Mauriziano, Torino, Italy.
Ciccia F; Rheumatology, University of Campania, Napoli, Italy.
Sarzi-Puttini P; Rheumatology Unit, ASST Fatebenefratelli-Sacco, University of Milan, Italy.
Perosa F; Department of Biomedical Science and Human Oncology, Rheumatologic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Bari, Italy.
Paolazzi G; UOC Reumatologia, Ospedale Santa Chiara, Trento, Italy.
Hollan I; Lillehammer Hospital for Rheumatic Diseases, Lillehammer, Norway and Brigham and Women's Hospital, Cardiology Division, Boston, USA.
Bendtzen K; Institute for Inflammation Research IIR 7521, Rigshospitalet Natl. Univ. Hospital Copenhagen, Denmark.
Meroni PL; Istituto Auxologico Italiano, IRCCS, Experimental Laboratory of Immuno-rheumatology, Milan, Italy. Electronic address: .
Borghi MO; Istituto Auxologico Italiano, IRCCS, Experimental Laboratory of Immuno-rheumatology, Milan, Italy; Department of Clinical Sciences and Community Health, University of Milan, Italy.
Pokaż więcej
Źródło :
Autoimmunity reviews [Autoimmun Rev] 2020 May; Vol. 19 (5), pp. 102509. Date of Electronic Publication: 2020 Mar 12.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Precision Medicine*
Antirheumatic Agents/*therapeutic use
Arthritis, Rheumatoid/*drug therapy
Arthritis, Rheumatoid/*immunology
Tumor Necrosis Factor Inhibitors/*therapeutic use
Adalimumab/therapeutic use ; Biosimilar Pharmaceuticals/therapeutic use ; Cross-Sectional Studies ; Etanercept/therapeutic use ; Female ; Humans ; Infliximab/therapeutic use ; Male ; Middle Aged ; Prospective Studies ; Treatment Outcome ; Tumor Necrosis Factor-alpha/antagonists & inhibitors
Czasopismo naukowe
Tytuł :
COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
Autorzy :
Sarzi-Puttini P; Rheumatology Unit, ASST-Fatebenefratelli L. Sacco University Hospital, University of Milan, Italy. .
Giorgi V; Rheumatology Unit, ASST-Fatebenefratelli L. Sacco University Hospital, University of Milan, Italy.
Sirotti S; Rheumatology Unit, ASST-Fatebenefratelli L. Sacco University Hospital, University of Milan, Italy.
Marotto D; Rheumatology Unit, ATS Sardegna, P. Dettori Hospital, Tempio Pausania, Italy.
Ardizzone S; Gastrointestinal Unit, ASST-Fatebenefratelli Sacco. L. Sacco Department of Biochemical and Clinical Sciences, University of Milan, Italy.
Rizzardini G; Department of Infectious Diseases, I Division of Infectious Diseases ASST Fatebenefratelli-Sacco, Milan, Italy.
Antinori S; Department of Biomedical and Clinical Sciences 'Luigi Sacco', University of Milan, and III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Galli M; Department of Biomedical and Clinical Sciences 'Luigi Sacco', University of Milan, and III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Pokaż więcej
Źródło :
Clinical and experimental rheumatology [Clin Exp Rheumatol] 2020 Mar-Apr; Vol. 38 (2), pp. 337-342. Date of Electronic Publication: 2020 Mar 22.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Betacoronavirus*
Coronavirus Infections*/drug therapy
Coronavirus Infections*/epidemiology
Coronavirus Infections*/immunology
Pandemics*
Pneumonia, Viral*/drug therapy
Pneumonia, Viral*/epidemiology
Pneumonia, Viral*/immunology
Anti-Inflammatory Agents/*therapeutic use
Antirheumatic Agents/*therapeutic use
Cytokines/*metabolism
China/epidemiology ; Humans ; Infection Control ; Severe Acute Respiratory Syndrome/drug therapy ; Severe Acute Respiratory Syndrome/epidemiology ; Severe Acute Respiratory Syndrome/immunology
SCR Disease Name :
COVID-19
Czasopismo naukowe
Tytuł :
Failure of anti-TNF treatment in patients with rheumatoid arthritis: The pros and cons of the early use of alternative biological agents.
Autorzy :
Rubbert-Roth A; Division of Rheumatology, Cantonal Hospital St Gallen, St Gallen, Switzerland. Electronic address: .
Szabó MZ; Buda Hospital of the Hospitaller Order of Saint John of God, Budapest, Hungary.
Kedves M; Bács-Kiskun County Hospital, Rheumatology Department, Kecskemét 6000, Balaton u. 17, Hungary.
Nagy G; Buda Hospital of the Hospitaller Order of Saint John of God, Budapest, Hungary; Department of Rheumatology, 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary; Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary.
Atzeni F; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Sarzi-Puttini P; Rheumatology Unit, Internal Medicine Department, ASST Fatebenefratelli-Sacco, Milan University School of Medicine, Milan, Italy.
Pokaż więcej
Źródło :
Autoimmunity reviews [Autoimmun Rev] 2019 Dec; Vol. 18 (12), pp. 102398. Date of Electronic Publication: 2019 Oct 19.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antirheumatic Agents/*therapeutic use
Arthritis, Rheumatoid/*drug therapy
Tumor Necrosis Factor-alpha/*therapeutic use
Biological Factors/therapeutic use ; Biological Therapy/methods ; Drug Substitution ; Female ; Humans
Czasopismo naukowe
Tytuł :
The therapeutic journey of biologic agents: There will be an end?
Autorzy :
Atzeni F; Rheumatology Unit, University of Messina, Messina, Italy. Electronic address: .
Sarzi-Puttini P; Department of Biomedical and Clinical Sciences L.Sacco, Università di Milano, Milano, Italy.
Pokaż więcej
Źródło :
Pharmacological research [Pharmacol Res] 2019 Sep; Vol. 147, pp. 104340. Date of Electronic Publication: 2019 Jul 02.
Typ publikacji :
Editorial
MeSH Terms :
Antirheumatic Agents/*therapeutic use
Biological Factors/*therapeutic use
Rheumatic Diseases/*drug therapy
Antirheumatic Agents/adverse effects ; Biological Factors/adverse effects ; Humans
Opinia redakcyjna
Tytuł :
Rate of serious infections in spondyloarthropathy patients treated with anti-tumour necrosis factor drugs: a survey from the Italian registry GISEA.
Autorzy :
Atzeni F; Rheumatology Unit, University of Messina, Italy. .
Sarzi-Puttini P; Rheumatology Unit, L. Sacco University Hospital, Milan, Italy.
Sebastiani M; University Hospital of Modena, Italy.
Panetta V; L'Altrastatistica Consultancy & Training, Biostatistics Office, Rome, Italy.
Salaffi F; Polytechnic University of Marche, C. Urbani Hospital, Jesi, Italy.
Iannone F; Rheumatology Unit, University of Bari, Italy.
Carletto A; Rheumatology Unit, University of Verona, Italy.
Foti R; Rheumatology Unit, Vittorio-Emanuele University Hospital of Catania, Italy.
Gremese E; Division of Rheumatology, Institute of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy.
Govoni M; Department of Medical Sciences, Division of Rheumatology, Santa Anna University Hospital, Ferrara, Italy.
Marchesoni A; G. Pini Orthopaedic Hospital, Milan, Italy.
Favalli E; G. Pini Orthopaedic Hospital, Milan, Italy.
Gorla R; Rheumatology and Immunology Unit, Spedali Civili, Brescia, Italy.
Ramonda R; University of Padova, Italy.
Ferraccioli G; Division of Rheumatology, Institute of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy.
Lapadula G; Rheumatology Unit, University of Bari, Italy.
Pokaż więcej
Corporate Authors :
GISEA group.
Źródło :
Clinical and experimental rheumatology [Clin Exp Rheumatol] 2019 Jul-Aug; Vol. 37 (4), pp. 649-655. Date of Electronic Publication: 2019 Feb 11.
Typ publikacji :
Journal Article
MeSH Terms :
Antirheumatic Agents/*adverse effects
Infections/*etiology
Spondylarthropathies/*complications
Tumor Necrosis Factor-alpha/*adverse effects
Adalimumab ; Adult ; Antirheumatic Agents/therapeutic use ; Etanercept ; Female ; Humans ; Infections/epidemiology ; Infliximab ; Italy ; Male ; Middle Aged ; Registries ; Spondylarthropathies/drug therapy ; Spondylarthropathies/immunology ; Surveys and Questionnaires ; Tumor Necrosis Factor-alpha/therapeutic use
Czasopismo naukowe
Tytuł :
Systemic rheumatic diseases: From biological agents to small molecules.
Autorzy :
Sarzi-Puttini P; Rheumatology Unit, ASST Fatebenefratelli-Sacco, University of Milan, Italy. Electronic address: .
Ceribelli A; Rheumatology Unit, ASST Fatebenefratelli-Sacco, University of Milan, Italy.
Marotto D; Rheumatology Unit, P-Dettori Hospital, Tempio Pausania, Italy.
Batticciotto A; Rheumatology Unit, Internal Medicine Department, ASST Settelaghi, Ospedale Di Circolo - Fondazione Macchi, Varese, Italy.
Atzeni F; Rheumatology Unit, University of Messina, Messina, Italy.
Pokaż więcej
Źródło :
Autoimmunity reviews [Autoimmun Rev] 2019 Jun; Vol. 18 (6), pp. 583-592. Date of Electronic Publication: 2019 Apr 05.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antirheumatic Agents/*therapeutic use
Rheumatic Diseases/*drug therapy
Biosimilar Pharmaceuticals/therapeutic use ; Humans
Czasopismo naukowe
Tytuł :
Treatment with golimumab or infliximab reduces health resource utilization and increases work productivity in patients with ankylosing spondylitis in the QUO-VADIS study, a large, prospective real-life cohort.
Autorzy :
Claudepierre P; Department of Rheumatology, Henri Mondor Hospital, APHP, and Université Paris Est Créteil, Créteil, France.
Van den Bosch F; Ghent University Hospital, Ghent, Belgium.
Sarzi-Puttini P; UOC Reumatologia, Ospedale L. Sacco Polo Universitario, Milan, Italy.
Vastesaeger N; MSD Belgium, Brussels, Belgium.
Govoni M; MSD Italy, Rome, Italy.
Kachroo S; Merck & Co., Inc, Kenilworth, New Jersey.
Pokaż więcej
Źródło :
International journal of rheumatic diseases [Int J Rheum Dis] 2019 Jun; Vol. 22 (6), pp. 995-1001. Date of Electronic Publication: 2019 Apr 15.
Typ publikacji :
Comparative Study; Journal Article; Observational Study
MeSH Terms :
Efficiency*
Work Performance*/economics
Antibodies, Monoclonal/*therapeutic use
Antirheumatic Agents/*therapeutic use
Infliximab/*therapeutic use
Spondylitis, Ankylosing/*drug therapy
Tumor Necrosis Factor Inhibitors/*therapeutic use
Absenteeism ; Adult ; Antibodies, Monoclonal/economics ; Antirheumatic Agents/economics ; Cost-Benefit Analysis ; Drug Costs ; Female ; Humans ; Infliximab/economics ; Male ; Presenteeism ; Prospective Studies ; Quality of Life ; Recovery of Function ; Sick Leave ; Spondylitis, Ankylosing/diagnosis ; Spondylitis, Ankylosing/economics ; Spondylitis, Ankylosing/physiopathology ; Time Factors ; Treatment Outcome ; Tumor Necrosis Factor Inhibitors/economics
Czasopismo naukowe
Tytuł :
Adverse events, clinical considerations and management recommendations in rheumatoid arthritis patients treated with JAK inhibitors.
Autorzy :
Atzeni F; a Rheumatology Unit, Department of Clinical and Experimental Medicine , University of Messina , Messina , Italy.
Talotta R; b Department of Clinical Pharmacology and Toxicology , University of Milan, Laboratory of Genetics, ASST Grande Ospedale Metropolitano Niguarda , Milan , Italy.
Nucera V; a Rheumatology Unit, Department of Clinical and Experimental Medicine , University of Messina , Messina , Italy.
Marino F; a Rheumatology Unit, Department of Clinical and Experimental Medicine , University of Messina , Messina , Italy.
Gerratana E; a Rheumatology Unit, Department of Clinical and Experimental Medicine , University of Messina , Messina , Italy.
Sangari D; a Rheumatology Unit, Department of Clinical and Experimental Medicine , University of Messina , Messina , Italy.
Masala IF; c Orthopedic and Trauma Unit , Santissima Trinità Hospital , Cagliari , Italy.
Sarzi-Puttini P; d Rheumatology Unit, Department of Internal Medicine , ASST-Fatebenefratelli L. Sacco University Hospital , Milan , Italy.
Pokaż więcej
Źródło :
Expert review of clinical immunology [Expert Rev Clin Immunol] 2018 Nov; Vol. 14 (11), pp. 945-956. Date of Electronic Publication: 2018 Aug 21.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antirheumatic Agents/*therapeutic use
Arthritis, Rheumatoid/*drug therapy
Azetidines/*therapeutic use
Piperidines/*therapeutic use
Pyrimidines/*therapeutic use
Pyrroles/*therapeutic use
Sulfonamides/*therapeutic use
Animals ; Azetidines/pharmacology ; Clinical Trials as Topic ; Humans ; Janus Kinase 1/antagonists & inhibitors ; Piperidines/pharmacology ; Pyrimidines/pharmacology ; Pyrroles/pharmacology ; Sulfonamides/pharmacology
Czasopismo naukowe
Tytuł :
The influence of comorbidities on the efficacy of tumour necrosis factor inhibitors, and the effect of tumour necrosis factor inhibitors on comorbidities in rheumatoid arthritis: report from a National Consensus Conference.
Autorzy :
Conti F; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome.
Atzeni F; Rheumatology Unit, University of Messina, Messina.
Massaro L; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome.
Chiara Gerardi M; Rheumatology Unit, University of Messina, Messina.
Gremese E; Division of Rheumatology, Fondazione Policlinico Gemelli, Catholic University of the Sacred Heart, Rome.
Passiu G; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Sassari, Sassari.
Carletto A; Rheumatology Unit, Department of Medicine, University Hospital, Verona.
Malavolta N; Gestione delle Malattie Reumatiche, Connettivo e Malattie Metaboliche dell'Osso AOU di Bologna, Policlinico S. Orsola-Malpighi, Bologna.
Foti R; Rheumatology Unit A.O.U. Policlinico V.E. Catania.
Ramonda R; Department of Rheumatology, University of Padova, Padova, Italy.
Sarzi-Puttini P; Rheumatology Unit, University of Messina, Messina.
Pokaż więcej
Źródło :
Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2018 Oct 01; Vol. 57 (57 Suppl 7), pp. vii11-vii22.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antirheumatic Agents/*therapeutic use
Arthritis, Rheumatoid/*drug therapy
Arthritis, Rheumatoid/*epidemiology
Cardiovascular Diseases/*epidemiology
Infections/*epidemiology
Neoplasms/*epidemiology
Tumor Necrosis Factor-alpha/*antagonists & inhibitors
Comorbidity/trends ; Consensus Development Conferences as Topic ; Global Health ; Humans
Czasopismo naukowe
Tytuł :
Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents.
Autorzy :
Atzeni F; Rheumatology Unit, University of Messina, Via Consolare Valeria 1, 98100, Messina, Italy. Electronic address: .
Talotta R; Post-graduate School of Pharmacology and Clinical Toxicology, University of Milan, Piazza Ospedale Maggiore 3, 20152, Milano, Italy. Electronic address: .
Masala IF; Orthopedic and Trauma Unit, Santissima Trinità Hospital, Via Is Mirrionis 92, 09121, Cagliari, Italy. Electronic address: .
Gerardi MC; Rheumatology Unit, Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy. Electronic address: .
Casale R; Habilita Hospitals & Research Rehabilitation Unit, Bergamo, Zingonia, Italy. Electronic address: .
Sarzi-Puttini P; Department of Rheumatology, University Hospital ASST-Fatebenefratelli-Sacco, Via GB Grassi 74, 20157, Milano, Italy. Electronic address: sarzi..
Pokaż więcej
Źródło :
Best practice & research. Clinical rheumatology [Best Pract Res Clin Rheumatol] 2018 Aug; Vol. 32 (4), pp. 500-510. Date of Electronic Publication: 2019 Feb 27.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antirheumatic Agents/*therapeutic use
Arthritis, Rheumatoid/*drug therapy
Arthritis, Rheumatoid/*etiology
Biological Factors/*therapeutic use
Central Nervous System/*pathology
Antirheumatic Agents/pharmacology ; Arthritis, Rheumatoid/pathology ; Biological Factors/pharmacology ; Humans
Czasopismo naukowe
Tytuł :
Clinical, Ultrasound, and Predictability Outcomes Following Certolizumab Pegol Treatment (with Methotrexate) in Patients with Moderate-to-Severe Rheumatoid Arthritis: 52-Week Results from the CZP-SPEED Study.
Autorzy :
Sarzi-Puttini P; Azienda Ospedaliera Luigi Sacco Polo Universitario, Milan, Italy.
Filippucci E; Università Politecnica delle Marche, Ancona, Italy.
Adami S; Università degli Studi di Verona, Azienda Ospedaliera di Verona, Verona, Italy.
Meroni PL; ASST Centro Ortopedico Traumatologico Gaetano Pini-CTO-Università degli Studi di Milano, Milan, Italy.
Batticciotto A; Azienda Ospedaliera Luigi Sacco Polo Universitario, Milan, Italy.
Idolazzi L; Università degli Studi di Verona, Azienda Ospedaliera di Verona, Verona, Italy.
De Lucia O; ASST Centro Ortopedico Traumatologico Gaetano Pini-CTO-Università degli Studi di Milano, Milan, Italy.
Talavera P; UCB Pharma, Madrid, Spain.
Kumke T; UCB Pharma, Monheim, Germany.
Grassi W; Università Politecnica delle Marche, Ancona, Italy. .
Pokaż więcej
Źródło :
Advances in therapy [Adv Ther] 2018 Aug; Vol. 35 (8), pp. 1153-1168. Date of Electronic Publication: 2018 Jul 24.
Typ publikacji :
Clinical Trial; Journal Article; Multicenter Study
MeSH Terms :
Antirheumatic Agents/*therapeutic use
Arthritis, Rheumatoid/*drug therapy
Certolizumab Pegol/*therapeutic use
Methotrexate/*therapeutic use
Adult ; Aged ; Drug Therapy, Combination ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Severity of Illness Index ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series.
Autorzy :
Talotta R; Department of Rheumatology, ASST Fatebenefratelli-Sacco, via GB Grassi n. 74, 20157, Milan, Italy. .
Atzeni F; Rheumatology Unit, University of Messina, via Consolare Valeria 1, 98100, Messina, Italy.
Batticciotto A; Department of Rheumatology, ASST Fatebenefratelli-Sacco, via GB Grassi n. 74, 20157, Milan, Italy.
Ditto MC; Department of Rheumatology, ASST Fatebenefratelli-Sacco, via GB Grassi n. 74, 20157, Milan, Italy.
Gerardi MC; Department of Rheumatology, ASST Fatebenefratelli-Sacco, via GB Grassi n. 74, 20157, Milan, Italy.
Sarzi-Puttini P; Department of Rheumatology, ASST Fatebenefratelli-Sacco, via GB Grassi n. 74, 20157, Milan, Italy.
Pokaż więcej
Źródło :
Journal of medical case reports [J Med Case Rep] 2018 Jun 03; Vol. 12 (1), pp. 154. Date of Electronic Publication: 2018 Jun 03.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Antibodies, Monoclonal, Humanized*/therapeutic use
Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*/drug therapy
Rheumatoid Nodule*/drug therapy
Aged ; Female ; Humans ; Male ; Methotrexate/therapeutic use ; Middle Aged
Czasopismo naukowe
Tytuł :
Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics' register GISEA.
Autorzy :
Iannone F; Rheumatology Unit, Department of Emergency Medicine and Transplantation, University of Bari, Bari, Italy. .; Rheumatology Unit, Interdisciplinary Department of Medicine, University of Bari, P.zza G. Cesare 11, 70124, Bari, Italy. .
Ferraccioli G; Institute of Rheumatology and Affine Sciences, Catholic University of the Sacred Heart, Rome, Italy.
Sinigaglia L; Department of Rheumatology, Gaetano Pini Institute, Milan, Italy.
Favalli EG; Department of Rheumatology, Gaetano Pini Institute, Milan, Italy.
Sarzi-Puttini P; L. Sacco University Hospital, Milan, Italy.
Atzeni F; L. Sacco University Hospital, Milan, Italy.
Gorla R; Rheumatology and Clinical Immunology Unit, Spedali Civili di Brescia, Brescia, Italy.
Bazzani C; Rheumatology and Clinical Immunology Unit, Spedali Civili di Brescia, Brescia, Italy.
Govoni M; Department of Medical Science, Section of Rheumatology, University of Ferrara and Azienda Ospedaliero Universitaria Sant'Anna di Cona, Ferrara, Italy.
Farina I; Department of Medical Science, Section of Rheumatology, University of Ferrara and Azienda Ospedaliero Universitaria Sant'Anna di Cona, Ferrara, Italy.
Gremese E; Institute of Rheumatology and Affine Sciences, Catholic University of the Sacred Heart, Rome, Italy.
Carletto A; Rheumatology Unit, University of Verona, Verona, Italy.
Giollo A; Rheumatology Unit, University of Verona, Verona, Italy.
Galeazzi M; Rheumatology Unit, University of Siena, Siena, Italy.
Foti R; Rheumatology Unit, A.O.U. Policlinico Vittorio Emanuele, Catania, Italy.
Bianchino L; Roche Spa, Monza, Italy.
La Grasta L; Roche Spa, Monza, Italy.
Lapadula G; Rheumatology Unit, Department of Emergency Medicine and Transplantation, University of Bari, Bari, Italy.
Pokaż więcej
Źródło :
Clinical rheumatology [Clin Rheumatol] 2018 Feb; Vol. 37 (2), pp. 315-321. Date of Electronic Publication: 2017 Oct 05.
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies, Monoclonal, Humanized/*therapeutic use
Antirheumatic Agents/*therapeutic use
Arthritis, Rheumatoid/*drug therapy
Biological Products/*therapeutic use
Abatacept/adverse effects ; Abatacept/therapeutic use ; Adult ; Antibodies, Monoclonal, Humanized/adverse effects ; Antirheumatic Agents/adverse effects ; Biological Products/adverse effects ; Female ; Humans ; Italy ; Male ; Middle Aged ; Registries ; Remission Induction/methods ; Treatment Outcome ; Tumor Necrosis Factor-alpha/antagonists & inhibitors
Czasopismo naukowe
Tytuł :
Ankylosing Spondylitis Treatment after First Anti-TNF Drug Failure.
Autorzy :
Benucci M; Rheumatology Unit, S. Giovanni di Dio Hospital, Florence, Italy.
Damiani A; Rheumatology Unit, S. Giovanni di Dio Hospital, Florence, Italy.
Bandinelli F; Rheumatology Unit, S. Giovanni di Dio Hospital, Florence, Italy.
Grossi V; Immunology and Allergology Laboratory Unit, S. Giovanni di Dio Hospital, Florence, Italy.
Infantino M; Immunology and Allergology Laboratory Unit, S. Giovanni di Dio Hospital, Florence, Italy.
Manfredi M; Immunology and Allergology Laboratory Unit, S. Giovanni di Dio Hospital, Florence, Italy.
Gobbi FL; Rheumatology Unit, S. Giovanni di Dio Hospital, Florence, Italy.
Sarzi-Puttini P; Rheumatology Unit, Sacco University Hospital, Milan, Italy.
Atzeni F; Rheumatology Unit, Sacco University Hospital, Milan, Italy.
Pokaż więcej
Źródło :
The Israel Medical Association journal : IMAJ [Isr Med Assoc J] 2018 Feb; Vol. 20 (2), pp. 119-122.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antirheumatic Agents/*therapeutic use
Spondylitis, Ankylosing/*drug therapy
Tumor Necrosis Factor-alpha/*antagonists & inhibitors
Antirheumatic Agents/adverse effects ; Antirheumatic Agents/pharmacology ; Humans ; Medication Adherence ; Spondylitis, Ankylosing/physiopathology ; Treatment Failure
Czasopismo naukowe
Tytuł :
Biological Agents in Rheumatoid Arthritis: A Cross-Link Between Immune Tolerance and Immune Surveillance.
Autorzy :
Talotta R; Rheumatology Unit, L. Sacco University Hospital, Milan, Italy.
Atzeni F; Rheumatology Unit, L. Sacco University Hospital, Milan, Italy.
Batticciotto A; Rheumatology Unit, L. Sacco University Hospital, Milan, Italy.
Benucci M; Rheumatology Unit, San Giovanni di Dio Hospital, Florence, Italy.
Bongiovanni S; Rheumatology Unit, L. Sacco University Hospital, Milan, Italy.
Sarzi-Puttini P; Rheumatology Unit, L. Sacco University Hospital, Milan, Italy.
Pokaż więcej
Źródło :
Current rheumatology reviews [Curr Rheumatol Rev] 2018; Vol. 14 (2), pp. 131-139.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antirheumatic Agents/*adverse effects
Arthritis, Rheumatoid/*drug therapy
Immune Tolerance/*drug effects
Immunologic Surveillance/*drug effects
Biological Factors/adverse effects ; Humans ; Neoplasms/chemically induced ; Opportunistic Infections/chemically induced
Czasopismo naukowe
Tytuł :
The Immunogenicity of Branded and Biosimilar Infliximab in Rheumatoid Arthritis According to Th9-Related Responses.
Autorzy :
Talotta R; Department of Rheumatology, Azienda Ospedaliera-Polo Universitario Luigi Sacco, Milan 20157, Italy. .
Berzi A; Department of Biomedical and Clinical Sciences, Azienda Ospedaliera-Polo Universitario Luigi Sacco, Milan 20157, Italy. .
Doria A; Department of Rheumatology, University of Padua, Padua 35100, Italy. .
Batticciotto A; Department of Rheumatology, Azienda Ospedaliera-Polo Universitario Luigi Sacco, Milan 20157, Italy. .
Ditto MC; Department of Rheumatology, Azienda Ospedaliera-Polo Universitario Luigi Sacco, Milan 20157, Italy. .
Atzeni F; Department of Rheumatology, Azienda Ospedaliera-Polo Universitario Luigi Sacco, Milan 20157, Italy. .
Sarzi-Puttini P; Department of Rheumatology, Azienda Ospedaliera-Polo Universitario Luigi Sacco, Milan 20157, Italy. sarzi@tiscali.it.
Trabattoni D; Department of Biomedical and Clinical Sciences, Azienda Ospedaliera-Polo Universitario Luigi Sacco, Milan 20157, Italy. .
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2017 Oct 12; Vol. 18 (10). Date of Electronic Publication: 2017 Oct 12.
Typ publikacji :
Journal Article
MeSH Terms :
Antirheumatic Agents/*adverse effects
Arthritis, Rheumatoid/*drug therapy
Arthritis, Rheumatoid/*immunology
Infliximab/*adverse effects
T-Lymphocytes, Helper-Inducer/*immunology
Adult ; Aged ; Antirheumatic Agents/immunology ; Antirheumatic Agents/therapeutic use ; Arthritis, Rheumatoid/metabolism ; Autoantibodies/immunology ; Autoantigens/immunology ; Biomarkers ; Female ; Humans ; Immunophenotyping ; Infliximab/immunology ; Infliximab/therapeutic use ; Male ; Middle Aged ; T-Lymphocytes, Helper-Inducer/drug effects ; T-Lymphocytes, Helper-Inducer/metabolism ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry.
Autorzy :
Manara M; Department of Rheumatology, Gaetano Pini Institute, Milan, Italy. .
Caporali R; Department of Rheumatology, University of Pavia, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
Favalli EG; Department of Rheumatology, Gaetano Pini Institute, Milan, Italy.
Grosso V; Department of Rheumatology, University of Pavia, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
Atzeni F; Rheumatology Unit, L. Sacco University Hospital, Milan, Italy.
Sarzi Puttini P; Rheumatology Unit, L. Sacco University Hospital, Milan, Italy.
Gorla R; Rheumatology and Immunology Unit, Spedali Civili, Brescia, Italy.
Bazzani C; Rheumatology and Immunology Unit, Spedali Civili, Brescia, Italy.
Fusaro E; Department of Rheumatology, Città della Salute e della Scienza, Torino, Italy.
Pellerito R; Rheumatology Unit, Ospedale Mauriziano, Torino, Italy.
Rocchetta PA; Rheumatology Unit, A.S.O. «SS.Antonio e Biagio e C.Arrigo», Alessandria, Italy.
Sinigaglia L; Department of Rheumatology, Gaetano Pini Institute, Milan, Italy.
Pokaż więcej
Źródło :
Clinical and experimental rheumatology [Clin Exp Rheumatol] 2017 Sep-Oct; Vol. 35 (5), pp. 804-809. Date of Electronic Publication: 2017 Jul 27.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Antibodies, Monoclonal/*therapeutic use
Antirheumatic Agents/*therapeutic use
Arthritis, Psoriatic/*drug therapy
Arthritis, Rheumatoid/*drug therapy
Spondylitis, Ankylosing/*drug therapy
Adult ; Aged ; Antibodies, Monoclonal/adverse effects ; Antirheumatic Agents/adverse effects ; Arthritis, Psoriatic/diagnosis ; Arthritis, Psoriatic/immunology ; Arthritis, Rheumatoid/diagnosis ; Arthritis, Rheumatoid/immunology ; Female ; Humans ; Italy ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Proportional Hazards Models ; Registries ; Retrospective Studies ; Spondylitis, Ankylosing/diagnosis ; Spondylitis, Ankylosing/immunology ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Infections in rheumatoid arthritis.
Autorzy :
Atzeni F; aIRCCS Galeazzi Orthopedic Institute, Milan bOrthopedic and Trauma Unit, Santissima Trinità Hospital, Cagliari cRheumatology Unit, Department of Internal Medicine and Medical Specialities, La Sapienza University of Rome, Rome dRheumatology Unit, L. Sacco University Hospital, Milan, Italy.
Masala IF
di Franco M
Sarzi-Puttini P
Pokaż więcej
Źródło :
Current opinion in rheumatology [Curr Opin Rheumatol] 2017 Jul; Vol. 29 (4), pp. 323-330.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antirheumatic Agents/*therapeutic use
Arthritis, Rheumatoid/*drug therapy
Infections/*epidemiology
Humans ; Risk Factors
Czasopismo naukowe
Tytuł :
Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries.
Autorzy :
Codullo V; Rheumatology Unit, University of Pavia, IRCCS Policlinico San Matteo, Pavia, Italy.
Iannone F; Interdisciplinary Department of Medicine-Rheumatology Unit, Policlinico, University of Bari, Italy.
Sinigaglia L; Rheumatology Unit, Ospedale G. Pini, Milan, Italy.
Favalli EG; Rheumatology Unit, Ospedale G. Pini, Milan, Italy.
Sarzi-Puttini P; Rheumatology Unit, Ospedale Sacco, Milan, Italy.
Atzeni F; IRCCS Galeazzi Orthopaedic Institute, Milan, Italy.
Ferraccioli G; Rheumatology Unit, Catholic University of the Sacred Heart, Rome, Italy.
Gremese E; Rheumatology Unit, Catholic University of the Sacred Heart, Rome, Italy.
Carletto A; Rheumatology Unit, University of Verona, Italy.
Giollo A; Rheumatology Unit, University of Verona, Italy.
Govoni M; Rheumatology Unit, University of Ferrara, Italy.
Bergossi F; Rheumatology Unit, University of Ferrara, Italy.
Galeazzi M; Rheumatology Unit, University of Siena, Italy.
Cantarini L; Rheumatology Unit, University of Siena, Italy.
Salaffi F; Rheumatology Unit, Università Politecnica delle Marche, Jesi, Italy.
Di Carlo M; Rheumatology Unit, Università Politecnica delle Marche, Jesi, Italy.
Bazzani C; Rheumatology Unit, University of Brescia, Italy.
Pellerito R; Rheumatology Unit, Ospedale Mauriziano, Torino, Italy.
Sebastiani M; Rheumatology Unit, University of Modena e Reggio Emilia, Italy.
Ramonda R; Rheumatology Unit, University of Padova, Italy.
Lapadula G; Interdisciplinary Department of Medicine-Rheumatology Unit, Policlinico, University of Bari, Italy.
Caporali R; Rheumatology Unit, University of Pavia, IRCCS Policlinico San Matteo, Pavia, Italy. .
Pokaż więcej
Źródło :
Clinical and experimental rheumatology [Clin Exp Rheumatol] 2017 Jul-Aug; Vol. 35 (4), pp. 660-665. Date of Electronic Publication: 2017 May 08.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Registries*
Adalimumab/*therapeutic use
Antirheumatic Agents/*therapeutic use
Arthritis, Rheumatoid/*drug therapy
Adrenal Cortex Hormones/therapeutic use ; Adult ; Aged ; Drug Therapy, Combination ; Female ; Humans ; Italy ; Male ; Methotrexate/therapeutic use ; Middle Aged ; Remission Induction ; Severity of Illness Index ; Treatment Failure
Czasopismo naukowe
Tytuł :
Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry.
Autorzy :
Monti S; Department of Rheumatology, IRCCS Policlinico San Matteo Foundation, University of Pavia, Viale Golgi 19, 27100, Pavia, Italy. .
Klersy C; Biometry and Clinical Epidemiology, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy.
Gorla R; Reumatologia, Spedali Civili, Brescia, Italy.
Sarzi-Puttini P; University Hospital L Sacco, Milan, Italy.
Atzeni F; University Hospital L Sacco, Milan, Italy.
Pellerito R; Ospedale Mauriziano, Turin, Italy.
Fusaro E; Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.
Paolazzi G; Santa Chiara Hospital, Trento, Italy.
Rocchetta PA; Struttura di Reumatologia A.S.O. 'SS. Antonio e Biagio e C. Arrigo', Alessandria, Italy.
Favalli EG; Department of Rheumatology, Gaetano Pini Institute, Milan, Italy.
Marchesoni A; Department of Rheumatology, Gaetano Pini Institute, Milan, Italy.
Caporali R; Department of Rheumatology, IRCCS Policlinico San Matteo Foundation, University of Pavia, Viale Golgi 19, 27100, Pavia, Italy.
Pokaż więcej
Źródło :
Clinical rheumatology [Clin Rheumatol] 2017 Apr; Vol. 36 (4), pp. 753-761. Date of Electronic Publication: 2017 Jan 05.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Antirheumatic Agents/*therapeutic use
Arthritis, Rheumatoid/*drug therapy
Biological Therapy/*methods
Abatacept/therapeutic use ; Aged ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antirheumatic Agents/adverse effects ; Biological Therapy/adverse effects ; Comorbidity ; Drug Therapy, Combination ; Female ; Humans ; Italy ; Logistic Models ; Male ; Methotrexate/therapeutic use ; Middle Aged ; Registries ; Tumor Necrosis Factor-alpha/antagonists & inhibitors ; Tumor Necrosis Factor-alpha/therapeutic use
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies